Rheumatoid Arthritis Treatment Dissatisfaction

It’s a good week to think about joint health, since we’re in the middle of Bone and Joint Action Week (October 12-20). One-third of adults need medical care for a joint/bone condition every year, and the numbers are only going up. In fact, joint or bone conditions rank as the most likely cause of a…

Cancer Silver Lining

For patients living with cancer (and even for their health care providers working day in and day out in the cancer field), sometimes it can be hard to find positivity. If you’re looking for a little bright spot about cancer, here’s something to keep in mind: current research suggests that older people who have survived…

Time Matters: From Diagnosis to Treatment

Each October brings an important time, Breast Cancer Awareness Month, and with it comes vital messages about screenings for breast cancer, along with education about risk factors and symptoms. One issue that doesn’t always get enough discussion is what happens right after a diagnosis. In fact, the timeliness of care delivery after diagnosis is an…

HCV Cure: Next Steps

Hepatitis C now ranks among the diseases that can nearly always be cured with appropriate treatment, which comes as a huge change compared to just a decade ago. However, after successfully treating hepatitis C virus (HCV) infection with direct-acting antiviral medications, there are still some things patients and their health care providers should keep in…

Prostate Cancer Awareness Month

September is prostate cancer awareness month, a disease that affects the lives of more than 3 million men every year across the globe. In the United States, one in nine men will learn of their diagnosis of prostate cancer in their lifetime, making this the second most common cancer in American men. Prostate cancer survival…

Food Allergy Links to MS

Multiple sclerosis, a complex autoimmune disease, appears to have several interesting diet connections. Food choices, of course, do not directly cause multiple sclerosis. MS results from a poorly understood combination of genetics and environmental factors. Age, gender, family history, certain infections, race, climate, smoking, weight, and a history of other autoimmune diseases all factor into…

Skyrizi’s Rise

The U.S. Food and Drug Administration approved a new treatment option for psoriasis patients earlier this year: AbbVie’s Skyrizi (risankizumab-rzaa). This medication, which is used as a subcutaneous injection, gained this approval after a series of studies showed a high rate of skin clearance in adults with severe plaque psoriasis using Skyrizi. Ready for even…

Cancer’s Economic Burden

When a patient learns of their cancer diagnosis, it veers them on to a new (and unexpected) path in life. This new path means navigating treatment plans – and it also creates new financial concerns for many patients. In short, cancer comes with a substantial economic burden for many patients. Based on the latest national…

Fracture Protection

Osteoporosis affects a lot of older adults. However, having the disease doesn’t have to mean being on the road to a disability. Preventing osteoporotic fractures is job #1 in this regard. Worldwide, 1 in 3 women over age 50 will experience osteoporotic fractures, as will 1 in 5 men aged 50+ – that’s a fracture…

Psoriasis Myth Vs. Fact

August is National Psoriasis Awareness Month, making it the perfect time to share information about this skin disease and dispel myths associated with it. All in all, there’s a lot that your average patient might be misunderstanding about psoriasis. Click here to get the medications your psoriasis patients need today! Myth #1: That skin rash…

Yawning With Psoriasis

A substantial percentage of the 7 million Americans with psoriasis experience fatigue as an additional unwelcome bother, along with the better known symptoms of dry, scaly, painful, and itchy patches of skin. Typical locations for psoriasis include the joints, face, neck, trunk, arms, hands, feet, and scalp. There are a variety of medications that a…

Saying Goodbye to Hepatitis C by 2030

Once again, we’re approaching the annual World Hepatitis Day that occurs each year on July 28th. The theme this year, “Find the Missing Millions,” reminds all of us that there continues to be 300 million people living with viral hepatitis worldwide who do not yet know that there’s a deadly disease in their blood. Getting…

Eat Right for Crohn’s Relief

Crohn’s disease, along with a similar condition called ulcerative colitis, together make up the disease category of inflammatory bowel disease. Approximately 1.6 million Americans have been diagnosed with inflammatory bowel diseases, with each year another 70,000 cases in the U.S. getting the news of this digestive complaint. Newly diagnosed Crohn’s disease patients – as well…

Breast Cancer Shouldn’t Come with Debt Collectors

The financial challenges that follow a breast cancer diagnosis can weigh heavily on a patient (and their family). Research confirms – that even more so than other cancers – breast cancer comes with considerable economic burden. These financial costs include the patient’s out-of-pocket portion for initial treatment, as well as management of treatment side effects….

Keytruda: The Good News Keeps Coming

Immunotherapy medications for cancer treatment have been a game changer for the oncology field – and none moreso than Keytruda (pembrolizumab). Keytruda initially gained FDA approval in 2014 for melanoma, with the cancer approvals expanded over the years to include advanced and metastatic cancers such as non-small cell lung cancer, head/neck cancers, Hodgkin’s lymphoma, stomach…

Walking Toward Cancer Survival

Observing the gait and walking pace of a cancer patient can serve as a sort of shorthand to assess overall patient health and even the chances of optimal treatment outcome. About a decade ago, researchers found that gait speed could be used in a general way to predict which patients might have greater challenges recovering…

Taltz: The Good News Keeps Coming

Taltz (ixekizumab, Eli Lilly), a biologic injection medication for psoriasis, shows a high level of effectiveness and the latest research demonstrates that the clear-skin response which so many patients benefit from when they use Taltz keeps up for at least four years after starting treatment. Taltz first became available in 2016 for moderate to severe…

Cancer Treatment Slowdowns

Prior authorizations can present one of the biggest obstacles to patients diagnosed with cancer. This conclusion emerged in recent discussions among experts from three groups: the American Medical Association, the American Society for Radiation Oncology, and the National Coalition for Cancer Survivorship. These experts gathered together to examine prior authorization practices and a key finding…